Mutations of key proteins in the RAS/RAF/MEK/ERK and PI3K/Akt/mTOR signaling cascades were described in malignant melanoma including BRAF (35–60%), NRAS (15–30%), and PTEN (8–15%) [3,4,5]. The gene discussed is NRAS; the disease is melanoma.